化学名称: (6R,7S,9R,10R,13S,16R,17S)-17-(((6R,7S,8R,9R,10R,13S,14S,16R,17S)-6,9-Difluoro-1,7-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbonothioyl)trisulfanne-1-carbonothioyl)-6,9-difluoro-1,7-dihydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
微笑: C[C@@]12[C@@H](C(SSSC([C@H]3[C@H](C)CC4C5[C@H](O)[C@H](F)C6=CC(C=C(O)[C@]6(C)[C@@]5(F)CC[C@]34C)=O)=S)=S)[C@H](C)C[C@@]1([H])[C@]7([H])[C@H](O)[C@H](F)C8=CC(C=C(O)[C@]8(C)[C@@]7(F)CC2)=O
Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC–NMR spectroscopy and HPLC–MS
Nisha Mistry a , Ismail M. Ismail b , Marco S. Smith c , Jeremy K. Nicholson d , John C. Lindon
Journal of Pharmaceutical and Biomedical Analysis 16 (1997) 697–705